Entry
Name
Coronavirus disease - COVID-19 - Ovis aries (sheep)
Description
Coronavirus disease of 2019 (COVID-19) is a highly contagious respiratory infection that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infects alveolar epithelial cells [mainly alveolar epithelial type 2 (AEC2) cells] through the angiotensin-converting enzyme 2 (ACE2) receptor. Upon the occupancy of ACE2 by SARS-CoV-2, the increased serum level of free Angiotensin II (Ang II) due to a reduction of ACE2-mediated degradation promotes activation of the NF-kappa B pathway via Ang II type 1 receptor (AT1R), followed by interleukin-6 (IL-6) production. SARS-CoV-2 also activates the innate immune system; macrophage stimulation triggers the overproduction of pro-inflammatory cytokines, including IL-6, and the "cytokine storm", which results in systemic inflammatory response syndrome and multiple organ failure. The combined effects of complement activation, dysregulated neutrophilia, endothelial injury, and hypercoagulability appear to be intertwined to drive the severe features of COVID-19.
Class
Human Diseases; Infectious disease: viral
BRITE hierarchy
Pathway map
Ortholog table
Organism
Ovis aries (sheep) [GN:
oas ]
Gene
101108228 NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X2 [KO:K02580 ]
443064 IL12A; interleukin-12 subunit alpha precursor [KO:K05406 ]
443472 IL12B; interleukin-12 subunit beta precursor [KO:K05425 ]
100135698 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A precursor [KO:K03158 ]
101103369 IL6R; interleukin-6 receptor subunit alpha isoform X1 [KO:K05055 ]
100294659 STAT3; signal transducer and activator of transcription 3 isoform X10 [KO:K04692 ]
443523 CSF3; granulocyte colony-stimulating factor isoform X1 [KO:K05423 ]
443400 CSF2; granulocyte-macrophage colony-stimulating factor precursor [KO:K05427 ]
442997 CXCL10; C-X-C motif chemokine 10 precursor [KO:K12671 ]
101109132 LOW QUALITY PROTEIN: small ribosomal subunit protein uS5 [KO:K02981 ]
780524 RPS2; small ribosomal subunit protein uS5 isoform X1 [KO:K02981 ]
101109246 RPS4X; small ribosomal subunit protein eS4, X isoform [KO:K02987 ]
101115487 RPS10; small ribosomal subunit protein eS10 isoform X2 [KO:K02947 ]
101120300 LOW QUALITY PROTEIN: small ribosomal subunit protein uS15-like [KO:K02953 ]
101102145 RPS14; small ribosomal subunit protein uS11 isoform X1 [KO:K02955 ]
541599 RPS15; small ribosomal subunit protein uS19 [KO:K02958 ]
101117120 LOW QUALITY PROTEIN: small ribosomal subunit protein uS8 [KO:K02957 ]
101106101 RPS19; small ribosomal subunit protein eS19 isoform X1 [KO:K02966 ]
114113983 LOW QUALITY PROTEIN: small ribosomal subunit protein uS12 [KO:K02973 ]
101104961 RPS24; small ribosomal subunit protein eS24 isoform X2 [KO:K02974 ]
101108004 RPS27; small ribosomal subunit protein eS27 isoform X2 [KO:K02978 ]
443297 ubiquitin-ribosomal protein eS31 fusion protein [KO:K02977 ]
100135694 RPS27A; ubiquitin-ribosomal protein eS31 fusion protein [KO:K02977 ]
101121859 RPS29; small ribosomal subunit protein uS14 isoform X2 [KO:K02980 ]
101106472 FAU; ubiquitin-like FUBI-ribosomal protein eS30 fusion protein isoform X2 [KO:K02983 ]
101102096 LOW QUALITY PROTEIN: small ribosomal subunit protein uS2 [KO:K02998 ]
105606693 LOW QUALITY PROTEIN: large ribosomal subunit protein uL4 [KO:K02930 ]
780462 RPL4; large ribosomal subunit protein uL4 [KO:K02930 ]
101110647 LOW QUALITY PROTEIN: large ribosomal subunit protein uL30 [KO:K02937 ]
101106166 LOW QUALITY PROTEIN: large ribosomal subunit protein uL1 [KO:K02865 ]
106990094 RPL10A; large ribosomal subunit protein uL1 isoform X1 [KO:K02865 ]
101111087 RPL12; large ribosomal subunit protein uL11 isoform X2 [KO:K02870 ]
443072 RPL13; large ribosomal subunit protein eL13 [KO:K02873 ]
100036760 RPL13A; large ribosomal subunit protein uL13 isoform X2 [KO:K02872 ]
121816084 LOW QUALITY PROTEIN: large ribosomal subunit protein eL14-like [KO:K02875 ]
101115926 C23H18orf32; UPF0729 protein C18orf32 homolog isoform X1 [KO:K02880 ]
106991069 LOW QUALITY PROTEIN: large ribosomal subunit protein uL22 [KO:K02880 ]
106991327 LOW QUALITY PROTEIN: large ribosomal subunit protein uL22 [KO:K02880 ]
100270789 RPL19; large ribosomal subunit protein eL19 isoform X1 [KO:K02885 ]
443070 RPL32; large ribosomal subunit protein eL32 [KO:K02912 ]
780467 RPL34; large ribosomal subunit protein eL34 [KO:K02915 ]
106990090 RPL35A; large ribosomal subunit protein eL33 isoform X6 [KO:K02917 ]
114115333 LOW QUALITY PROTEIN: large ribosomal subunit protein eL37-like [KO:K02922 ]
443296 UBA52; ubiquitin-ribosomal protein eL40 fusion protein [KO:K02927 ]
101106730 low affinity immunoglobulin gamma Fc region receptor II-like isoform X3 [KO:K06472 ]
101109759 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922 ] [EC:2.7.1.153 ]
101110015 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ]
101117348 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X3 [KO:K00922 ] [EC:2.7.1.153 ]
101123247 PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649 ]
101111546 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X2 [KO:K02649 ]
101121455 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X3 [KO:K02649 ]
101103341 PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116 ] [EC:3.1.4.11 ]
101122126 PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859 ] [EC:3.1.4.11 ]
678682 MYD88; myeloid differentiation primary response protein MyD88 [KO:K04729 ]
101122114 TAB2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404 ]
780484 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X2 [KO:K07209 ] [EC:2.7.11.10 ]
101107699 NLRP3; NACHT, LRR and PYD domains-containing protein 3 isoform X1 [KO:K12800 ]
101119838 MAVS; mitochondrial antiviral-signaling protein isoform X1 [KO:K12648 ]
101116050 STING1; stimulator of interferon genes protein isoform X1 [KO:K12654 ]
443126 IFNAR1; interferon alpha/beta receptor 1 precursor [KO:K05130 ]
443363 IFNAR2; interferon alpha/beta receptor 2 precursor [KO:K05131 ]
100307049 STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220 ]
101108211 STAT2; signal transducer and activator of transcription 2 isoform X1 [KO:K11221 ]
443146 MX1; interferon-induced GTP-binding protein Mx1 [KO:K14754 ]
780441 MX2; interferon-induced GTP-binding protein Mx2 [KO:K14754 ]
101121673 EIF2AK2; interferon-induced, double-stranded RNA-activated protein kinase isoform X1 [KO:K16195 ] [EC:2.7.11.1 ]
101102126 C1QA; complement C1q subcomponent subunit A isoform X1 [KO:K03986 ]
101123189 C1QC; complement C1q subcomponent subunit C isoform X1 [KO:K03988 ]
101111065 MASP1; mannan-binding lectin serine protease 1 isoform X1 [KO:K03992 ] [EC:3.4.21.-]
Compound
Reference
Authors
Harrison AG, Lin T, Wang P
Title
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis.
Journal
Reference
Authors
Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G
Title
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19.
Journal
Reference
Authors
Battagello DS, Dragunas G, Klein MO, Ayub ALP, Velloso FJ, Correa RG
Title
Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission.
Journal
Reference
Authors
Felsenstein S, Herbert JA, McNamara PS, Hedrich CM
Title
COVID-19: Immunology and treatment options.
Journal
Reference
Authors
Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, Hirano T
Title
How COVID-19 induces cytokine storm with high mortality.
Journal
Reference
Authors
Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I
Title
COVID-19 cytokine storm: The anger of inflammation.
Journal
Reference
Authors
Farooqi F, Dhawan N, Morgan R, Dinh J, Nedd K, Yatzkan G
Title
Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
Journal
Reference
Authors
Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, Walzer T, Francois B, Seve P
Title
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.
Journal
Reference
Authors
Kiselevskiy M, Shubina I, Chikileva I, Sitdikova S, Samoylenko I, Anisimova N, Kirgizov K, Suleimanova A, Gorbunova T, Varfolomeeva S
Title
Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
Journal
Reference
Authors
Curran CS, Rivera DR, Kopp JB
Title
COVID-19 Usurps Host Regulatory Networks.
Journal
Reference
Authors
Quan C, Li C, Ma H, Li Y, Zhang H
Title
Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.
Journal
Reference
Authors
Ahmed-Hassan H, Sisson B, Shukla RK, Wijewantha Y, Funderburg NT, Li Z, Hayes D Jr, Demberg T, Liyanage NPM
Title
Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
Journal
Reference
Authors
Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP
Title
The trinity of COVID-19: immunity, inflammation and intervention.
Journal
Reference
Authors
Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, Menachery VD, Rajsbaum R, Shi PY
Title
Evasion of Type I Interferon by SARS-CoV-2.
Journal
Reference
Authors
Hartenian E, Nandakumar D, Lari A, Ly M, Tucker JM, Glaunsinger BA
Title
The molecular virology of coronaviruses.
Journal
Reference
Authors
Amor S, Fernandez Blanco L, Baker D
Title
Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
Journal
Reference
Authors
Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C
Title
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
Journal
Reference
Authors
Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M
Title
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
Journal
Reference
Authors
Merad M, Martin JC
Title
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.
Journal
Reference
Authors
South AM, Tomlinson L, Edmonston D, Hiremath S, Sparks MA
Title
Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.
Journal
Reference
Authors
Furuhashi M, Moniwa N, Takizawa H, Ura N, Shimamoto K
Title
Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19.
Journal
Reference
Authors
Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V
Title
COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
Journal
Reference
Authors
Kielian M
Title
Enhancing host cell infection by SARS-CoV-2.
Journal
Reference
Authors
Risitano AM, Mastellos DC, Huber-Lang M, Yancopoulou D, Garlanda C, Ciceri F, Lambris JD
Title
Complement as a target in COVID-19?
Journal
Reference
Authors
Noris M, Benigni A, Remuzzi G
Title
The case of complement activation in COVID-19 multiorgan impact.
Journal
Reference
Authors
Polycarpou A, Howard M, Farrar CA, Greenlaw R, Fanelli G, Wallis R, Klavinskis LS, Sacks S
Title
Rationale for targeting complement in COVID-19.
Journal
Reference
Authors
Teuwen LA, Geldhof V, Pasut A, Carmeliet P
Title
COVID-19: the vasculature unleashed.
Journal
Reference
Authors
Jodele S, Kohl J
Title
Tackling COVID-19 infection through complement-targeted immunotherapy.
Journal
Reference
Authors
Chauhan AJ, Wiffen LJ, Brown TP
Title
COVID-19: A collision of complement, coagulation and inflammatory pathways.
Journal
Reference
Authors
Colling ME, Kanthi Y
Title
COVID-19-associated coagulopathy: An exploration of mechanisms.
Journal
Reference
Authors
McFadyen JD, Stevens H, Peter K
Title
The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.
Journal
Reference
Authors
Shi M, Wang L, Fontana P, Vora S, Zhang Y, Fu TM, Lieberman J, Wu H
Title
SARS-CoV-2 Nsp1 suppresses host but not viral translation through a bipartite mechanism.
Journal
Reference
Authors
Paniri A, Akhavan-Niaki H
Title
Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.
Journal
Reference
Authors
Omarjee L, Janin A, Perrot F, Laviolle B, Meilhac O, Mahe G
Title
Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.
Journal
Reference
Authors
Zhang S, Li L, Shen A, Chen Y, Qi Z
Title
Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia.
Journal
Related pathway
oas04270 Vascular smooth muscle contraction
oas04610 Complement and coagulation cascades
oas04613 Neutrophil extracellular trap formation
oas04620 Toll-like receptor signaling pathway
oas04621 NOD-like receptor signaling pathway
oas04622 RIG-I-like receptor signaling pathway
oas04650 Natural killer cell mediated cytotoxicity
oas04666 Fc gamma R-mediated phagocytosis
oas04670 Leukocyte transendothelial migration
KO pathway
LinkDB
All DBs